AHK-Cu may potentially become a member of the expanding family of copper-based therapies targeted at neuronal preservation, inflammation reduction, and regeneration if research keeps moving forward in the same direction, combining computational discoveries with useful biomedical testing
Dosing should be set by a prescribing provider
None of this would have been possible without the support of our incredible patients, our amazing community, our CEO Evan Miller, Ph.D., and the camaraderie and friendship of hundreds of Gameday franchise owners across the country
Ruiz J, Kouiavskaia D, Migliorini M, Robinson S, Saenko EL, Gorlatova N, et al
[DOI] [PubMed] [Google Scholar] 144.Petkov V., Radomirov R
description of dosage per insurance guidelines